{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:28:39Z","timestamp":1778858919911,"version":"3.51.4"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>To evaluate the relationship between the initial follicle stimulating hormone (FSH) dose and the number of available cleavage-stage embryos in <jats:italic>in vitro<\/jats:italic> fertilization (IVF) cycles.We included 8772 fresh IVF cycles using a GnRH antagonist protocol at the Genetic and Reproductive Institution of Chongqing, P. R. China, from January 2016 to June 2021.Univariate linear regression was used to evaluate the associations between the initial FSH dosage (\u2264 150, 187.5\u2013200, 225, 250, or 300 IU) with the number of available cleavage-stage embryos on day 3.\u00a0A two-factor linear regression model was applied to calculate the threshold effect of the initial FSH dosage on the number of available cleavage-stage embryos based on a smoothing plot. The initial FSH dose was negatively correlated with the number of available cleavage-stage embryos, independent of female age, body mass index, infertility factors, duration of infertility, anti-M\u00fcllerian hormone and basal FSH levels, antral follicle count and the proportions of patients with poor ovarian response or polycystic ovarian syndrome. Using a two-factor linear regression model, we calculated the inflection point to be 200 IU of FSH. The relationship between the initial FSH dose and the number of available cleavage-stage embryos was nonlinear. The initial FSH dose was negatively associated with the number of available cleavage-stage embryos when the initial FSH dose was &amp;gt; 200 IU. Therefore, clinicians should try to avoid unnecessarily increasing the initial FSH dose.<\/jats:p>","DOI":"10.3389\/fendo.2022.986438","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T04:47:10Z","timestamp":1665982030000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["High initial FSH dosage reduces the number of available cleavage-stage embryos in a GnRH-antagonist protocol: Real-world data of 8,772 IVF cycles from China"],"prefix":"10.3389","volume":"13","author":[{"given":"Xiu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Pei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubiao","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.04.039","article-title":"Cumulative live birth rates according to the number of oocytes retrieved after the first ovarian stimulation for in vitro fertilization\/intracytoplasmic sperm injection: a multicenter multinational analysis including \u223c15,000 women","volume":"110","author":"Polyzos","year":"2018","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"D12693","DOI":"10.1002\/14651858.CD012693.pub2","article-title":"Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF\/ICSI)","volume":"2","author":"Lensen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1093\/biolre\/ioaa210","article-title":"Negative impact of high doses of follicle-stimulating hormone during superovulation on the ovulatory follicle function in small ovarian reserve dairy heifers\u2020","volume":"104","author":"Karl","year":"2021","journal-title":"Biol Reprod"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.07.1151","article-title":"Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles","volume":"104","author":"Baker","year":"2015","journal-title":"Fertil Steril"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.04.027","article-title":"Total follicle stimulating hormone dose is negatively correlated with live births in a donor\/recipient model with fresh transfer: an analysis of 8,627 cycles from the society for assisted reproductive technology registry","volume":"114","author":"Shaia","year":"2020","journal-title":"FERTIL STERIL"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/0093-691X(85)90181-5","article-title":"Superovulation of beef heifers with pergonal (HMG): A dose response trial","volume":"24","author":"McGowan","year":"1985","journal-title":"Theriogenology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/0093-691X(86)90059-2","article-title":"Induction of superovulation in cyclic heifers: The inhibitory effect of large doses of PMSG","volume":"25","author":"Saumande","year":"1986","journal-title":"Theriogenology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0093-691X(86)90233-5","article-title":"Superovulation of beef cows with FSH-p: a dose response trial","volume":"179","author":"Pawlyshyn","year":"1986","journal-title":"Theriogenology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/0093-691X(90)90509-R","article-title":"Superovulation of beef heifers with folltropin: A new FSH preparation containing reduced LH activity","volume":"33","author":"Gonzalez","year":"1990","journal-title":"Theriogenology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0378-4320(93)90107-3","article-title":"Superovulation of cattle with a recombinant-DNA bovine follicle stimulating hormone","volume":"33","author":"Wilson","year":"1993","journal-title":"Anim Reprod"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1292\/jvms.59.223","article-title":"Use of highly purified porcine FSH preparation for superovulation in Japanese black cattle","volume":"59","author":"Sugano","year":"1997","journal-title":"J Vet Med Sci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1051\/rnd:2002046","article-title":"Recent advances in the superovulation in cattle","volume":"42","author":"Mapletoft","year":"2002","journal-title":"Reprod Nutr Dev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1051\/rnd:2002045","article-title":"Superovulation in cattle: practical aspects of gonadotropin treatment and insemination","volume":"42","author":"Kanitz","year":"2002","journal-title":"Reprod Nutr Dev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.theriogenology.2006.03.026","article-title":"Superovulatory response of sistani cattle to three different doses of FSH during winter and summer","volume":"66","author":"Barati","year":"2006","journal-title":"Theriogenology"},{"key":"B15","article-title":"Effect of semen source and dose of FSH on superovulatory response and embryo production in Holstein heifers","volume":"4","author":"Souza","year":"2007","journal-title":"Anim Reprod"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1199018","article-title":"An upper limit of gonadotropin dose in patients undergoing ART should be advocated","volume":"32","author":"Friedler","year":"2016","journal-title":"GYNECOL Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex094","article-title":"High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers","volume":"32","author":"Munch","year":"2017","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-018-4884-4","article-title":"Factors affecting the live-birth rate in women with diminished ovarian reserve undergoing IVF-ET","volume":"298","author":"Huang","year":"2018","journal-title":"Arch GYNECOL OBSTET"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-011-9630-9","article-title":"Effects of cumulus cells removal after 6 h co-incubation of gametes on the outcomes of human IVF","volume":"28","author":"Xiong","year":"2011","journal-title":"J Assist Reprod Genet"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(11)60012-6","article-title":"Individualizing FSH dose for assisted reproduction using a novel algorithm: the CONSORT study","volume":"22","author":"Olivennes","year":"2011","journal-title":"Reprod BioMed Online"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.03.027","article-title":"What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders","volume":"94","author":"Berkkanoglu","year":"2010","journal-title":"Fertil Steril"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2016.1199018","article-title":"An upper limit of gonadotropin dose in patients undergoing ART should be advocated","volume":"32","author":"Friedler","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S1472-6483(10)60654-2","article-title":"Impact of duration and dose of gonadotrophins on IVF outcomes","volume":"13","author":"Martin","year":"2006","journal-title":"Reprod BioMed Online"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertil Steril"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04583-1","article-title":"A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-f*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment","volume":"79","author":"Yong","year":"2003","journal-title":"Fertil Steril"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/humupd\/dms041","article-title":"Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach","volume":"19","author":"Broer","year":"2013","journal-title":"Hum Reprod Update"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/humupd\/dmr037","article-title":"The poor responder in IVF: is the prognosis always poor?: a systematic review","volume":"18","author":"Oudendijk","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh663","article-title":"Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial","volume":"20","author":"Klinkert","year":"2005","journal-title":"Hum Reprod"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dex318","article-title":"Individualized versus standard FSH dosing in women starting IVF\/ICSI: an RCT. part 1: The predicted poor responder","volume":"32","author":"van Tilborg","year":"2017","journal-title":"Hum Reprod"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-008-9266-6","article-title":"Increased gonadotrophin stimulation does not improve IVF outcomes in patients with predicted poor ovarian reserve","volume":"25","author":"Lekamge","year":"2008","journal-title":"J Assist Reprod Genet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/humrep\/15.1.29","article-title":"Increasing the daily dose of recombinant follicle stimulating hormone (Puregon) does not compensate for the age-related decline in retrievable oocytes after ovarian stimulation","volume":"15","author":"Out","year":"2000","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.5935\/1518-0557.20170058","article-title":"FSH dose to stimulate different patient' ages: when less is more","volume":"21","author":"Borges","year":"2017","journal-title":"JBRA Assist Reprod"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2007.05.055","article-title":"Less is more: increased gonadotropin use for ovarian stimulation adversely influences clinical pregnancy and live birth after in vitro fertilization","volume":"89","author":"Pal","year":"2008","journal-title":"Fertil Steril"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev263","article-title":"Cumulative live birth rate: time for a consensus","volume":"30","author":"Maheshwari","year":"2015","journal-title":"Hum Reprod"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/mrd.20128","article-title":"Hormonal control of somatic cell oocyte interactions during ovarian follicle development","volume":"69","author":"Combelles","year":"2004","journal-title":"Mol Reprod Dev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod.104.032003","article-title":"Follicle-stimulating hormone affects metaphase I chromosome alignment and increases aneuploidy in mouse oocytes matured in vitro","volume":"72","author":"Roberts","year":"2005","journal-title":"Biol Reprod"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det014","article-title":"High FSH decreases the developmental potential of mouse oocytes and resulting fertilized embryos, but does not influence offspring physiology and behavior in vitro or in vivo","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"B40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12958-019-0489-4","article-title":"Effect of exogenous gonadotropin on the transcriptome of human granulosa cells and follicular fluid hormone profiles","volume":"17","author":"Lu","year":"2019","journal-title":"Reprod Biol Endocrinol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del484","article-title":"Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial","volume":"22","author":"Baart","year":"2007","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000445658","article-title":"High serum FSH is associated with brown oocyte formation and a lower pregnacy rate in human IVF parctice","volume":"39","author":"Xu","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s40618-014-0204-4","article-title":"Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation","volume":"38","author":"Levi","year":"2015","journal-title":"J Endocrinol Invest"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.986438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T04:47:15Z","timestamp":1665982035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.986438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":43,"alternative-id":["10.3389\/fendo.2022.986438"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.986438","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"article-number":"986438"}}